Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 7/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.61 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.61 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6352101 | 0.88 | ALB (0.80) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6346566 | 0.87 | ALB (1.00) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6356873 | 0.87 | ALB (1.00) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6349461 | 0.87 | ALB (1.00) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL13870890 | 0.87 | ALB (1.00) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6353213 | 0.86 | ALB (0.80) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL13532208 | 0.86 | ALB (0.82) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6349549 | 0.85 | ALB (0.76) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL6353328 | 0.85 | ALB (0.81) | ALBKMT2AALDH1A1MEN1GAA | |
| SCHEMBL13532201 | 0.84 | KMT2A (1.00) | KMT2AALDH1A1MEN1GAATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | ALB 1682/4885KMT2A 3645/4885ALDH1A1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.